Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-019884
Filing Date
2020-07-21
Accepted
2020-07-21 19:44:24
Documents
1
Period of Report
2020-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 32209
  Complete submission text file 0000899243-20-019884.txt   33712
Mailing Address C/O MOMENTA PHARMACEUTICALS, INC. 43 MOULTON STREET CAMBRIDGE MA 02138
Business Address
Crane Alan L (Reporting) CIK: 0001294361 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39381 | Film No.: 201039955

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Issuer) CIK: 0001807901 (see all company filings)

EIN.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations